Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference3%
- Check25 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check39 days agoChange DetectedPage updated to v3.0.2 from v3.0.1, indicating a new release. The 'Back to Top' link was removed, with no other core content, pricing, stock, or scheduling information appearing to change.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as various scientific techniques and proteins, while removing several terms related to antineoplastic agents and immune checkpoint inhibitors.SummaryDifference2%
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.